Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05870488 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction

Study acronym: STACI
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Feb 6, 2026, no change to tracked fieldsv11-v12
  2. Primary completion date changed from estimate of May 2025 to Apr 23, 2025
    • Study description expanded, about 1 word
    v10
  3. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 17 to 14
    • Primary completion date: May 2026 to May 2025
    • Study completion date: May 2026 to Nov 2027
    v9
  4. Study sites: 16 to 17v8
  5. Study sites: 15 to 16v7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites: 14 to 15v6
  2. Study sites: 12 to 14v5
  3. Study sites: 7 to 12v4
  4. Study sites: 4 to 7v3
  5. Study sites: 2 to 4
    • Start date changed from estimate of May 2023 to May 23, 2023
    • Secondary endpoints revised (8)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.
Trial Details
NCT Number NCT05870488
Lead Sponsor SI-BONE, Inc.
Conditions
(from sponsor)		 Sacroiliac Joint Dysfunction, Sacroiliac; Fusion, Sacroiliac Disorder, Sacroiliac Joint Pain
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov